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tern populations. This article describes selected genetic causes for inherited pediatric cataract in the region.
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Non-traumatic pediatric cataract is uncommon. Unilateral
cases are often idiopathic and typically occur in the smaller
eye with persistent fetal vasculature that can range from
subtle to obvious. Bilateral cases are more likely to have a
systemic association or a detectable cause such as malnutri-
tion, metabolic imbalance, infection, drug exposure, or gene
mutation. For those cases of apparently non-syndromic con-
genital or childhood-onset (juvenile) cataract caused by gene
mutations, the most obvious candidates are genes responsi-
ble for normal lens structure such as lens structural proteins,
lens cytoskeletal proteins, certain collagens, and/or ocular
transcription factors. Many such gene mutations have been
described, particularly for genes that encode the crystallins,
which are the major water-soluble structural component of
the lens.1–3 In general the ability to make phenotype-
genotype correlations in hereditary pediatric cataract is
limited because of variable expressivity (phenotypes) for a
given genotype and overlapping phenotypes for different
genotypes; however, there are exceptions.
In Arab countries, epidemiological and genetic data
regarding hereditary pediatric cataract are lacking. In the
West, studies have shown that up to one-third of the bilateralPeer review under responsibility
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However, these statistics are not applicable to Saudi Arabia
or to the surrounding countries.5 While dominant causes oc-
cur, the social preference for intrafamilial marriage and a
large number of children is expected to increase expression
of potential homozygous recessive disease and thus the inci-
dence of both known and novel recessive causes for heredi-
tary cataract. This has been my experience from genetic
counseling of affected Saudi families. The current report illus-
trates selected genetic causes for hereditary pediatric cata-
ract on the Arabian Peninsula.Lens structure (crystallins)
Crystallins comprise the major structural component of the
human lens.1 Thus it is not surprising that mutations in the
crystallin genes are estimated to account for approximately
half of non-syndromic hereditary pediatric cataract.3 Three
major mammalian crystallin groups are distinguishable based
on size, charge and immunological properties: alpha (a), beta
(b), and gamma (c).1
Most reported crystallin mutations are dominant1–3; how-
ever, in my experience, most Saudi families with hereditaryj Production and hosting by ElsevierAccess this article online: www.saudiophthaljournal.comwww.sciencedirect.com
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68 A.O. Khancataract tend to harbor recessive crystallin mutations. This is
often in one of the b-crystallins (unpublished data).Figure 2. Although some of her affected relatives with recessive CRYAB
mutation (p.R56W) had total white cataract within the first few years of
life, the ocular phenotype of this girl harboring the recessive mutation
consists of asymptomatic punctate lens opacities. This demonstrates
variable expressivity for a cataract-causing recessive mutation.
Figure 3. This woman had cataract surgery in early childhood for CRYAB-
related cataract (recessive p.R56W mutation) and was left aphakic.
Decades later she developed retinal degeneration. This was presumably
related to disruption of the normal anti-apoptotic function of retinal
CRYAB in the setting of many years of unfiltered light reaching the retina.Selected example 1 – a-crystallin (CRYAA and CRYAB)
a-crystallin, the major protein component of the mamma-
lian lens, is an aggregate comprised of 2 gene products:
alpha-A (from the gene CRYAA) and alpha-B (from the
gene CRYAB).1 a-crystallin facilitates the correct folding of
other lenticular proteins in vivo, and thus it is important in
suppressing protein aggregation and maintaining lens
transparency.
CRYAA encodes the alpha-A component of a-crystallin and
is expressed mainly in the lens.1 Most reported mutations are
dominant.2 One of the two reported recessive CRYAA
mutations (p.R54C) caused congenital white cataract in a
consanguineous nuclear family from the southern Arabian
Peninsula with 3 out of 10 children affected.6 Affected
children also had microcornea, which may have been from
abnormal cornea induction by the abnormally-formed lens
(Fig. 1). In that family asymptomatic mutation carriers were
documented to have asymptomatic lenticular opacities, a clin-
ical heterozygote carrier sign that had not been previously
documented for recessive cataract.6
CRYAB encodes the alpha-B component of a-crystallin.
Unlike CRYAA, CRYAB has a relatively broad expression pat-
tern that includes muscle and retina, where it serves a protec-
tive anti-apoptotic function.1 Virtually all reported mutations
are dominant, with phenotypes that can include myopathy
with or without cataract. A recessive p.R56W CRYAB muta-
tion was documented in a Saudi family from the eastern Ara-
bian Peninsula.7,8 In that family, of the 12 studied family
members 7 were homozygous for the mutation. These homo-
zygous individuals had lens phenotypes that ranged from sig-
nificant congenital cataract to visually-insignificant lens
opacities during childhood or adulthood (Fig. 2). This was sig-
nificant because it demonstrated variable expressivity for the
same pathological genotype, a phenomenon that had been
well-documented for dominant cataract9 but not for reces-
sive cataract. Variable expressivity for familial cataract is re-
lated to the influence of other background genetic factors
and/or environment. Interestingly, those family members
homozygous for the CRYAB mutation who were left aphakic
after childhood cataract surgery developed retinal degenera-
tion decades later while those individuals homozygous for
the mutation who were made pseudophakic or left phakic
did not.7,8 This was possibly from impaired anti-apoptotic
CRYAB function in the retina and highlights how environment
(unfiltered light in an aphakia as opposed to pseudophakia orFigure 1. This child with recessive CRYAA mutation (p.R54C) had
infantile cataract surgery and was fitted with aphakic glasses. The
associated microcornea can be appreciated.phakia) can potentially interact with underlying genotype (the
CRYAB mutation as expressed in the retina) to cause pheno-
typic consequences (Fig. 3).
Selected example 2 – c-D-crystallin (CRYGD)
Both c-crystallins and b-crystallins are comprised of homol-
ogous Greek key motifs with 2 domains. The major differ-
ences are that c-crystallins are monomeric and lack terminal
extensions. Of the c-crystallins, only CRYGC and CRYGD
are significantly expressed in the human lens.10 A specific
founder dominant mutation in CRYGD (p.P23T) was docu-
mented as the cause for a unique phenotype of juvenile ceru-
lean cataract in Saudi children from 2 different families
(Fig. 4).11 Haplotype analysis confirmed that the mutation
was from a single founder. One affected sibling who har-
bored the mutation had coralliform cataract, suggesting that
coralliform and cerulean cataract represent variable expres-
sivity for the genotype rather than distinct conditions.11 Inter-
Figure 4. The classic cerulean cataract phenotype is shown in a Saudi
child. The cause in this child, dominant p.P23T CRYGD mutation, was also
found to underly the phenotype in another Saudi family. These 2 Saudi
families were not known to be related but haplotype analysis suggested
they inherited the mutation from a common ancestor.
igure 5. At approximately 12 years of age, this girl and her affected
isters became symptomatic from juvenile cataract due to recessive
PSP2 mutation (p.A201RfsX19). This cataract is from impairment in a
ytoskeletal protein and its morphology is unique – diffuse cortical
ataract with scattered lens opacities.
Figure 6. In this asymptomatic female harboring an NHS mutation, the Y-
centered lens opacities are a clinical carrier sign.
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associated with cerulean or coralliform cataract once before
in a Moroccan family,12,13 raising the possibility that the
affected individuals in the Saudi families and the Moroccan
family inherited the mutation from a common ancestor.11
Lens cytoskeletal proteins
Lens cytoskeletal proteins are important in optimal lens fi-
ber cell organization such that the crystalline lens maintains
its optical properties. Mutations in these genes can give un-
ique phenotypes.
Selected example 1 – beaded filament structural
protein 2 (BFSP2)
BFSP2 is an intermediate filament protein highly ex-
pressed in the lens and critical to proper lens fiber architec-
ture.14 Dominant cataract-causing mutations have been
described.14 The one documented recessive BFSP2 mutation
was in a Saudi family from the northern Arabian Peninsula
(p.A201RfsX19).15 Three sisters out of 9 siblings developed
a unique phenotype of juvenile-onset diffuse cortical cataract
with scattered fleck lens opacities at approximately 12 years
of age (Fig. 5).15 The carrier mother did not have significant
lens opacities while the carrier father had had surgery for
posterior subcapsular cataract in his mid-forties, which seems
to have been coincidental. The recessive BFSP2 mutation in
this family did not seem to have manifestations in the carrier
(heterozygous) state and thus likely lacked the ability to
assemble, polymerize, or interfere with the normal protein
when in the carrier state. This was unlike the previously-re-
ported mutations in this gene, which were dominant and pre-
sumably interfered with normal lens fiber maintenance.15
Selected example 2 – NHS
The gene NHS encodes a regulator of actin remodeling
and cell morphology and is particularly expressed in the lens,
brain, craniofacial mesenchyme, and dental primordia.16
Mutations in NHS cause the Nance-Horan syndrome, an
often under-diagnosed X-linked developmental disorder




ccornea in boys.16 Non-ophthalmic features include particular
facial features (long face, bulbous nose, rotated ears, dental
abnormalities), variable mental retardation (up to 30%
of affected boys), and shortened lateral metacarpals.17 For
ophthalmic X-linked disease in general, females from
affected families can be asymptomatic despite harboring
the gene mutation and can potentially be clinically identified
by certain carrier signs. The study of a large affected Saudi
family harboring NHS mutation from the western Arabian
Peninsula has provided insight into female carrier signs for
Nance-Horan syndrome (Ophthalmic Genetics, in press).
The 4 genetically-confirmed asymptomatic female carriers
of a specific NHS mutation could be identified clinically by
their characteristic Y-centered lens opacities (Fig. 6) in addi-
tion to their characteristic facial features. No potential female
carrier without these findings from the family was a carrier for
the NHS mutation, not even a potential female carrier with
punctate lens opacities (that were not Y-centered).Certain collagens
Collagens are a heterogeneous group of extracellular gly-
coproteins with a triple helical domain motif that have differ-
ent structural and matrix functions throughout the body.
Figure 8. In addition to the cortical wedge-shaped partial cataract,
vitreous degeneration immediately posterior to the lens is another helpful
sign in diagnosing Stickler syndrome.
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protean manifestations. In some instances, they result in char-
acteristic forms of congenital or juvenile cataract that if rec-
ognized can be helpful in the diagnosis of certain syndromes.
Selected example 1 – collagen type II alpha 1
(COL2A1, Stickler syndrome)
Sticker syndrome is a clinical diagnosis with variable fea-
tures but characterized by midface hypoplasia, hearing loss,
spondyloepiphyseal dysplasia, and ophthalmic findings. Oph-
thalmic findings include high myopia, vitreoretinal degenera-
tion, a propensity for retinal detachments, and a
characteristic wedge-shaped partial cataract. Although cata-
racts in Stickler syndrome do not always have this specific mor-
phology, when it is present it should raise suspicion for the
diagnosis (Fig. 7). The etiology for this particular cataract mor-
phology is unclear. Stickler syndrome is genetically heteroge-
neous, although many cases seem to be caused by dominant
mutation in COL2A1, a fibrillar collagen highly expressed in
the vitreous and cartilage.18 Interestingly, patients with muta-
tion in exon 2 of COL2A1 have a predominantly ocular pheno-
type with minimal extraocular features.19 The findings of
partial cataract and vitreous degeneration (Fig. 8) in a child
should raise suspicion for ocular Stickler syndrome, especially
in the setting of high myopia. While dominant COL2A1 muta-
tions cause the cataract associated with Stickler syndrome in
Saudi Arabia as they do in the rest of the world, in this region
the phenotype is also caused by recessive mutations in other
collagen genes (unpublished data).
Selected example 2 – collagen type XVIII alpha-1
(COL18A1, Knobloch syndrome)
Collagen XVIII alpha-1 is one of the multiplexins, extracel-
lular matrix proteins that contain multiple triple-helix do-
mains interrupted by non-collagenous domains.20 The
proteolytically produced C-terminal fragment of type XVIII
collagen is endostatin, a potent antiangiogenic protein. The
short isoform of collagen XVIII is expressed in brain, retina,
and vascular and epithelial basement membranes throughout
the body.20,21 Recessive mutations in COL18A1 causeFigure 7. In Stickler syndrome, cortical wedge-shaped partial cataract is
a classic finding. Although cataracts in Sticker syndrome do not always
have this morphology, when it is present it is helpful in diagnosing the
syndrome.Knobloch syndrome, characterized by occipital defect, high
myopia, vitreoretinal degeneration, and a propensity for ret-
inal detachments.20,22 Ectopia lentis also often occurs. Af-
fected children tend to develop a characteristic peripheral
crescentic lens opacity that when present is helpful in con-
firming the diagnosis. In fact, when present with other ocular
features that characterize the syndrome, in my experience
the ocular phenotype becomes pathognomonic for the diag-
nosis of Knobloch syndrome. The etiology of this particular
lens morphology is not known.
Ocular transcription factors
Normal anterior segment development is dependent
upon several genes that orchestrate and regulate the forma-
tion of the eye, examples of which include but are not limited
to PAX6, FOXC1, and PITX2. Dominant mutation in one of
these transcription factors is a potential cause of hereditary
cataract, often in the context of other ocular developmental
disease and sometimes also in the context of non-ocular find-
ings. Phenotypic variability and overlap from mutations in
these genes often occur.
Selected example: paired box gene 6 (PAX6)
PAX6 is a transcription factor with an instrumental role in
orchestrating ocular development.23 Recessive PAX6 muta-
tions are lethal.24 Dominant PAX6 mutations cause aniridia,
a pan-ocular disorder that can affect the conjunctiva, cornea,
lens, iris, trabecular meshwork, fovea, and/or optic nerve.
The classic anirida phenotype is specific for dominant PAX6
mutation although infrequently patients with the classic ani-
ridia phenotype do not have detectable PAX6 mutation.23,25
When an insult that causes PAX6 mutation also disrupts the
neighboring gene WT1, which is more likely in sporadic
cases, affected children have a predisposition to Wilms tumor
of the kidney.26
PAX6 mutations do not always cause an obvious aniridic
phenotype.23 Variant phenotypes can occur, particularly with
missense mutations.27 In fact, PAX6 mutations can cause
seemingly-isolated congenital or juvenile cataract.24,27 The
morphology of PAX6-related cataract varies, but anterior
Hereditary pediatric cataract on the Arabian Peninsula 71polar lens opacities are common. As is true for generally for
dominant disease, on the Arabian Peninsula PAX6-related
phenotypes are not expected to be more or less frequent
than in the rest of the world.
Summary
There are many potential genetic etiologies for hereditary
pediatric cataract. In the West, familial pediatric cataract is
often dominant. While dominant mutations are a potential
cause on the Arabian Peninsula, in this region of the world
recessive causes comprise a larger percentage of cases and
some of these causes are unique. Additional studies regard-
ing the epidemiology and genetics of hereditary pediatric
cataract in the region are needed, both to further under-
standing of crystalline lens pathophysiology and also to im-
prove local genetic counseling services.
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